Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 1, Pages 191
Publisher
MDPI AG
Online
2022-01-04
DOI
10.3390/cancers14010191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
- (2021) K.N. Moore et al. ANNALS OF ONCOLOGY
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Folate transporter dynamics and therapy with classic and tumor-targeted antifolates
- (2021) Carrie O’Connor et al. Scientific Reports
- T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review
- (2021) Jessica W. Y. Wu et al. Frontiers in Immunology
- Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors
- (2021) Camilla Nero et al. Cancers
- A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)
- (2021) Luca Falzone et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Structural basis of antifolate recognition and transport by PCFT
- (2021) Joanne L. Parker et al. NATURE
- MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway
- (2021) Qiutong Li et al. FEBS Open Bio
- Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
- (2021) Bayley G. Matthews et al. Cancers
- SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
- (2020) Juan C. García-Cañaveras et al. LEUKEMIA
- Exploiting the folate receptor α in oncology
- (2020) Mariana Scaranti et al. Nature Reviews Clinical Oncology
- Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer
- (2020) Aamod S. Dekhne et al. MOLECULAR CANCER THERAPEUTICS
- Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells that Can Be Reprogrammed with Folate-Targeted Drugs.
- (2020) Gregory M. Cresswell et al. CANCER RESEARCH
- Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment
- (2020) Katherine C. Kurnit et al. OBSTETRICS AND GYNECOLOGY
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Serine Metabolism Supports Macrophage IL-1β Production
- (2019) Arianne E. Rodriguez et al. Cell Metabolism
- Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold
- (2019) Junya Kawai et al. ACS Medicinal Chemistry Letters
- Re-education of macrophages as a therapeutic strategy in cancer
- (2019) Joanna Kowal et al. Immunotherapy
- Novel pyrrolo[3,2-d]pyrimidine compounds target mitochondrial and cytosolic one-carbon metabolism with broad-spectrum antitumor efficacy
- (2019) Aamod S. Dekhne et al. MOLECULAR CANCER THERAPEUTICS
- One-Carbon Metabolism Supports S-Adenosylmethionine and Histone Methylation to Drive Inflammatory Macrophages
- (2019) Weiwei Yu et al. MOLECULAR CELL
- Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer
- (2019) R. Nilsson et al. GENE
- Discovery of a Potent, Selective, and Orally Available MTHFD2 Inhibitor (DS18561882) with in Vivo Antitumor Activity
- (2019) Junya Kawai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
- (2019) Aamod S. Dekhne et al. MOLECULAR PHARMACOLOGY
- Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
- (2019) Sudeep Gupta et al. Journal of Ovarian Research
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Fluorine-Substituted Pyrrolo[2,3-d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis
- (2018) Manasa Ravindra et al. JOURNAL OF MEDICINAL CHEMISTRY
- miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
- (2018) Anne-Marie Givel et al. Nature Communications
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate
- (2018) Christian Brand et al. EJNMMI Research
- Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells
- (2018) Yuxiang Zheng et al. CELL
- SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism
- (2018) Nora Kory et al. SCIENCE
- The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption
- (2017) Rongbao Zhao et al. MOLECULAR ASPECTS OF MEDICINE
- Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3- d ]pyrimidine Antifolates
- (2017) Zhanjun Hou et al. MOLECULAR CANCER THERAPEUTICS
- Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma
- (2017) Gregory S. Ducker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A New View into the Regulation of Purine Metabolism: The Purinosome
- (2017) Anthony M. Pedley et al. TRENDS IN BIOCHEMICAL SCIENCES
- The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels
- (2017) Gerta Hoxhaj et al. Cell Reports
- PARP inhibitors in ovarian cancer: evidence, experience and clinical potential
- (2017) Tarra Evans et al. Therapeutic Advances in Medical Oncology
- BRCA mutation in ovarian cancer: testing, implications and treatment considerations
- (2017) Robert T. Neff et al. Therapeutic Advances in Medical Oncology
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment
- (2016) Genichiro Ishii et al. ADVANCED DRUG DELIVERY REVIEWS
- Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies
- (2016) STERGIOS BOUSSIOS et al. ANTICANCER RESEARCH
- Crystal Structure of the Emerging Cancer Target MTHFD2 in Complex with a Substrate-Based Inhibitor
- (2016) Robert Gustafsson et al. CANCER RESEARCH
- Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway
- (2016) Gregory S. Ducker et al. Cell Metabolism
- Divergent evolution of vitamin B9 binding underlies Juno-mediated adhesion of mammalian gametes
- (2016) Ling Han et al. CURRENT BIOLOGY
- A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse
- (2016) Ignace Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Profile of farletuzumab and its potential in the treatment of solid tumors
- (2016) Seiya Sato et al. OncoTargets and Therapy
- Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
- (2016) Quirijn R.J.G. Tummers et al. Oncotarget
- Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments
- (2015) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications
- (2015) Ignace B. Vergote et al. CANCER AND METASTASIS REVIEWS
- 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors
- (2015) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes
- (2015) Talha Badar et al. LEUKEMIA RESEARCH
- IMGN853, a Folate Receptor- (FR )-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FR -Expressing Tumors
- (2015) O. Ab et al. MOLECULAR CANCER THERAPEUTICS
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Pathobiology of ovarian carcinomas
- (2015) Mojgan Devouassoux-Shisheboran et al. Chinese Journal of Cancer
- Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors
- (2015) Ignace Vergote et al. Therapeutic Advances in Medical Oncology
- Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
- (2015) Isaiah G. Schauer et al. NEOPLASIA
- Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
- (2014) M Köbel et al. BRITISH JOURNAL OF CANCER
- Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer
- (2014) Y. Wen et al. CLINICAL CANCER RESEARCH
- The folate receptor as a rational therapeutic target for personalized cancer treatment
- (2014) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Mammalian Mitochondrial and Cytosolic Folylpolyglutamate Synthetase Maintain the Subcellular Compartmentalization of Folates
- (2014) Scott A. Lawrence et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
- (2014) Roland Nilsson et al. Nature Communications
- Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia
- (2014) J. Ye et al. Cancer Discovery
- Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy
- (2014) Seiya Sato et al. Therapeutic Advances in Medical Oncology
- Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer
- (2014) Emily K. Colvin Frontiers in Oncology
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity
- (2013) JianMin Lin et al. CANCER BIOLOGY & THERAPY
- Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer
- (2013) Deborah K. Armstrong et al. GYNECOLOGIC ONCOLOGY
- PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
- (2013) R. Wendel Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- The human proton-coupled folate transporter
- (2012) Sita Kugel Desmoulin et al. CANCER BIOLOGY & THERAPY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- The Antifolates
- (2012) Michele Visentin et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors
- (2012) Patricia M. LoRusso et al. JOURNAL OF CLINICAL ONCOLOGY
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic strategies in epithelial ovarian cancer
- (2012) Ayako Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and Mutation
- (2012) Maria Ines Nunez et al. Journal of Thoracic Oncology
- Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed
- (2012) Daniel C. Christoph et al. Journal of Thoracic Oncology
- A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer
- (2012) Lana E Kandalaft et al. Journal of Translational Medicine
- Paradoxical Impact of Two Folate Receptors, FRα and RFC, in Ovarian Cancer: Effect on Cell Proliferation, Invasion and Clinical Outcome
- (2012) Michelle K. Y. Siu et al. PLoS One
- Mechanisms of Membrane Transport of Folates into Cells and Across Epithelia
- (2011) Rongbao Zhao et al. Annual Review of Nutrition
- Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity
- (2011) Joseph R. Bertino et al. CANCER BIOLOGY & THERAPY
- Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion
- (2011) Yuan Zhang et al. CANCER LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tetrahydrofolate Recognition by the Mitochondrial Folate Transporter
- (2011) Scott A. Lawrence et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis, Biological, and Antitumor Activity of a Highly Potent 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitor with Proton-Coupled Folate Transporter and Folate Receptor Selectivity over the Reduced Folate Carrier That Inhibits β-Glycinamide Ribonucleotide Formyltransferase
- (2011) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
- (2011) Yu-Li Chen et al. Molecular Oncology
- Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors Based on Selective Uptake by the Proton-Coupled Folate Transporter
- (2011) S. Kugel Desmoulin et al. MOLECULAR PHARMACOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
- (2011) Gooitzen M van Dam et al. NATURE MEDICINE
- Compartmentalization of Mammalian Folate-Mediated One-Carbon Metabolism
- (2010) Anne S. Tibbetts et al. Annual Review of Nutrition
- 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
- (2010) N. Issaeva et al. CANCER RESEARCH
- Pemetrexed Indirectly Activates the Metabolic Kinase AMPK in Human Carcinomas
- (2010) S. B. Rothbart et al. CANCER RESEARCH
- Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation
- (2010) Kiyomi Takaishi et al. CANCER SCIENCE
- Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor , in Epithelial Ovarian Cancer: a Phase I Study
- (2010) J. A. Konner et al. CLINICAL CANCER RESEARCH
- Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer
- (2010) Bryan T.J. Hennessy et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis and Antitumor Activity of a Novel Series of 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitors of Purine Biosynthesis with Selectivity for High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier for Cellular Entry
- (2010) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the Proton-Coupled Folate Transporter for Selective Delivery of 6-Substituted Pyrrolo[2,3-d]Pyrimidine Antifolate Inhibitors of De Novo Purine Biosynthesis in the Chemotherapy of Solid Tumors
- (2010) S. K. Desmoulin et al. MOLECULAR PHARMACOLOGY
- Breast Cancers: MR Imaging of Folate-Receptor Expression with the Folate-Specific Nanoparticle P1133
- (2010) Reinhard Meier et al. RADIOLOGY
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
- (2009) Taku Nagai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Folate Receptor Is Expressed by Tumor-Associated Macrophages and Constitutes a Marker for M2 Anti-inflammatory/Regulatory Macrophages
- (2009) A. Puig-Kroger et al. CANCER RESEARCH
- Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands
- (2009) Flora Vernooij et al. GYNECOLOGIC ONCOLOGY
- Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal trancriptional regulatory region in an antifolate-resistant HeLa cell line
- (2009) N. K. Diop-Bove et al. MOLECULAR CANCER THERAPEUTICS
- The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
- (2009) Susan J. Ramus et al. Molecular Oncology
- PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cells
- (2008) Nitzan Gonen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Embryonic development in the reduced folate carrier knockout mouse is modulated by maternal folate supplementation
- (2008) Janee Gelineau-van Waes et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Synthesis and Discovery of High Affinity Folate Receptor-Specific Glycinamide Ribonucleotide Formyltransferase Inhibitors with Antitumor Activity
- (2008) Yijun Deng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploratory Study of 99mTc-EC20 Imaging for Identifying Patients with Folate Receptor-Positive Solid Tumors
- (2008) R. E. Fisher et al. JOURNAL OF NUCLEAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started